Beck Capital Management’s INTROGEN THERAPEUTICS INC INGN Stock Holding History

Beck Capital Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,000	Closed	–	–	166
2015 Q4	$0	Buy	+26,000	New	–	﹤0.01%	158
2015 Q3	–	Sell	-26,000	Closed	–	–	159
2015 Q2	$0	Buy	+26,000	New	–	﹤0.01%	155

Beck Capital Management's INGN Position: Q1 2016 in Review

Beck Capital Management sold out of INTROGEN THERAPEUTICS INC (INGN) in Q1 2016, closing a stake of 26,000 shares.

Beck Capital Management first reported a position in INGN in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q4 2015. 0 funds tracked by Wall St. Rank hold INGN as of Q1 2016.

Beck Capital Management reported no remaining INTROGEN THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
Beck Capital Management sold 26,000 INTROGEN THERAPEUTICS INC shares in Q1 2016.
Beck Capital Management first reported a position in INTROGEN THERAPEUTICS INC in Q2 2015 and held it in 2 quarters.
Beck Capital Management's INTROGEN THERAPEUTICS INC position peaked at $0 in Q4 2015.
0 funds tracked by Wall St. Rank held INTROGEN THERAPEUTICS INC as of Q1 2016.

Based on Beck Capital Management's 13F filing for Q1 2016, filed 13 May 2016.